Matches in SemOpenAlex for { <https://semopenalex.org/work/W4214549433> ?p ?o ?g. }
- W4214549433 endingPage "1184" @default.
- W4214549433 startingPage "1184" @default.
- W4214549433 abstract "Non-small cell lung cancer (NSCLC) with anaplastic lymphoma kinase rearrangement (ALK) was first reported in 2007. ALK-rearranged NSCLC accounts for about 3-8% of NSCLC. The first-line therapy for ALK-rearranged advanced NSCLC is tyrosine kinase inhibitors (TKI) targeting ALK. Following the development of crizotinib, the first ALK-TKI, patient prognosis has been greatly improved. Currently, five TKIs are approved by the FDA. In addition, clinical trials of the novel TKI, ensartinib, and fourth-generation ALK-TKI for compound ALK mutation are ongoing. Treatment with angiogenesis inhibitors and immune checkpoint inhibitors is also being studied. However, as the disease progresses, cancers tend to develop resistance mechanisms. In addition to ALK mutations, other mechanisms, including the activation of bypass signaling pathways and histological transformation, cause resistance, and the identification of these mechanisms is important in selecting subsequent therapy. Studies on tissue and liquid biopsy have been reported and are expected to be useful tools for identifying resistance mechanisms. The purpose of this manuscript is to provide information on the recent clinical trials of ALK-TKIs, angiogenesis inhibitors, immune checkpoint inhibitors, and chemotherapy to describe tissue and liquid biopsy as a method to investigate the mechanisms of resistance against ALK-TKIs and suggest a proposed treatment algorithm." @default.
- W4214549433 created "2022-03-02" @default.
- W4214549433 creator A5001757711 @default.
- W4214549433 creator A5008560120 @default.
- W4214549433 creator A5010566372 @default.
- W4214549433 creator A5088416811 @default.
- W4214549433 date "2022-02-24" @default.
- W4214549433 modified "2023-09-27" @default.
- W4214549433 title "Review of Therapeutic Strategies for Anaplastic Lymphoma Kinase-Rearranged Non-Small Cell Lung Cancer" @default.
- W4214549433 cites W1531048613 @default.
- W4214549433 cites W1969391810 @default.
- W4214549433 cites W1990626198 @default.
- W4214549433 cites W2007739717 @default.
- W4214549433 cites W2011937137 @default.
- W4214549433 cites W2019539885 @default.
- W4214549433 cites W2027337735 @default.
- W4214549433 cites W2038586807 @default.
- W4214549433 cites W2041835001 @default.
- W4214549433 cites W2050249255 @default.
- W4214549433 cites W2055402151 @default.
- W4214549433 cites W2065477010 @default.
- W4214549433 cites W2074782882 @default.
- W4214549433 cites W2081095165 @default.
- W4214549433 cites W2082020673 @default.
- W4214549433 cites W2091493266 @default.
- W4214549433 cites W2094903176 @default.
- W4214549433 cites W2099530756 @default.
- W4214549433 cites W2104340741 @default.
- W4214549433 cites W2104347254 @default.
- W4214549433 cites W2113327188 @default.
- W4214549433 cites W2134787029 @default.
- W4214549433 cites W2139110945 @default.
- W4214549433 cites W2140333474 @default.
- W4214549433 cites W2147038864 @default.
- W4214549433 cites W2163351155 @default.
- W4214549433 cites W2168106545 @default.
- W4214549433 cites W2168635759 @default.
- W4214549433 cites W2198093519 @default.
- W4214549433 cites W2202341402 @default.
- W4214549433 cites W2232613537 @default.
- W4214549433 cites W2287350478 @default.
- W4214549433 cites W2295354328 @default.
- W4214549433 cites W2400514548 @default.
- W4214549433 cites W2482427906 @default.
- W4214549433 cites W2492871464 @default.
- W4214549433 cites W2529194187 @default.
- W4214549433 cites W2560367415 @default.
- W4214549433 cites W2564366019 @default.
- W4214549433 cites W2572174216 @default.
- W4214549433 cites W2581996620 @default.
- W4214549433 cites W2597638610 @default.
- W4214549433 cites W2613260339 @default.
- W4214549433 cites W2624310346 @default.
- W4214549433 cites W2738181268 @default.
- W4214549433 cites W2748599797 @default.
- W4214549433 cites W2751382641 @default.
- W4214549433 cites W2785110924 @default.
- W4214549433 cites W2789601608 @default.
- W4214549433 cites W2791185794 @default.
- W4214549433 cites W2791886669 @default.
- W4214549433 cites W2803802743 @default.
- W4214549433 cites W2803976856 @default.
- W4214549433 cites W2807519281 @default.
- W4214549433 cites W2810717836 @default.
- W4214549433 cites W2839057355 @default.
- W4214549433 cites W2889170871 @default.
- W4214549433 cites W2889233880 @default.
- W4214549433 cites W2890523839 @default.
- W4214549433 cites W2892935819 @default.
- W4214549433 cites W2894476389 @default.
- W4214549433 cites W2894810765 @default.
- W4214549433 cites W2898157040 @default.
- W4214549433 cites W2899668190 @default.
- W4214549433 cites W2911858378 @default.
- W4214549433 cites W2920658753 @default.
- W4214549433 cites W2923683745 @default.
- W4214549433 cites W2925139051 @default.
- W4214549433 cites W2937887865 @default.
- W4214549433 cites W2939485990 @default.
- W4214549433 cites W2946166987 @default.
- W4214549433 cites W2963997426 @default.
- W4214549433 cites W2967398721 @default.
- W4214549433 cites W2978074062 @default.
- W4214549433 cites W2978677918 @default.
- W4214549433 cites W2980670340 @default.
- W4214549433 cites W2981063657 @default.
- W4214549433 cites W2981645518 @default.
- W4214549433 cites W2987053327 @default.
- W4214549433 cites W2991400485 @default.
- W4214549433 cites W2991627091 @default.
- W4214549433 cites W2992931937 @default.
- W4214549433 cites W3001249325 @default.
- W4214549433 cites W3002978961 @default.
- W4214549433 cites W3005583371 @default.
- W4214549433 cites W3007665819 @default.
- W4214549433 cites W3011331060 @default.
- W4214549433 cites W3022131485 @default.
- W4214549433 cites W3027882342 @default.